SCHEMBL96088

SCHEMBL96088

N#Cc1ccc2c(c1)c1ccccc1c(=O)n2Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.50
SRC P12931 1/20 0.50
PDE9A O76083 1/20 0.50
PDE1C Q14123 1/20 0.50
P2RX4 Q99571 1/20 0.48
HDAC8 Q9BY41 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC1 Q13547 1/20 0.47
MAPT P10636 3/20 0.46
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
BRD4 O60885 1/20 0.45
CYP19A1 P11511 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPK1 P28482 1/20 0.45
LMNA P02545 1/20 0.44
PGR P06401 2/20 0.44
MAPK8 P45983 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96715 0.92 CFTR (0.49) CFTRSRCPDE9APDE1CP2RX4
SCHEMBL11754704 0.87 CYP19A1 (0.55) CFTRSRCPDE9APDE1CP2RX4
SCHEMBL97588 0.86 PTGER4 (0.54) PGRRORARORCRORB
SCHEMBL7098938 0.77 ALDH1A1 (0.63) CFTRHDAC8HDAC6HDAC1MAPT
SCHEMBL23789536 0.77 CYP19A1 (0.64) CFTRSRCPDE9APDE1CP2RX4
SCHEMBL96124 0.77 SRC (0.51) SRCP2RX4MAPTMEN1KMT2A
SCHEMBL6240183 0.76 TDP1 (0.52) CFTRSRCHDAC8HDAC6HDAC1
SCHEMBL14392803 0.75 ALDH1A1 (0.67) SRCP2RX4MAPTMEN1KMT2A
SCHEMBL6856259 0.74 L3MBTL1 (0.45) CFTRHDAC8HDAC6HDAC1MAPT
SCHEMBL2864205 0.73 PDE9A (0.63) PDE9APDE1CP2RX4MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
CN-101068810-B Carbostyril compound OTSUKA PHARMA CO LTD 2011-02-09 CN disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
CN-101068810-A Carbostyril compound OTSUKA PHARMA CO LTD (JP) 2007-11-07 CN disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 CFTR 159/4885SRC 394/4885PDE9A 4146/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 CFTR 159/4885SRC 394/4885PDE9A 4146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.